By MICHAEL J. de la MERCED
A successful purchase, pegged for about $45 billion, would be the latest deal in healthcare, a spree that has ranged from drug makers to insurance providers.
Published: July 27, 2015 at 12:00AM
Read more at: NYT Business Day